Using ONCOhabitats to plan brain tumor surgery
Part of Cancer clinical trials.
This study tests a computer tool called ONCOhabitats that helps doctors plan surgery and treatment for a type of aggressive brain tumor called glioblastoma. By using your MRI scans, the tool may help guide the surgeon to remove as much tumor as possible while sparing healthy brain tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a high-grade glioma (a type of fast-growing brain tumor) seen on MRI
- You are scheduled to have surgery to remove the tumor
- You have had a complete MRI scan before surgery, including specific types of images
- You are willing to sign a consent form to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
This study tests whether using artificial intelligence to plan radiation therapy can improve treatment for people with a newly diagnosed type of brain tumor called glioblastoma. If you qualify, you would receive radiation therapy planned with the help of a computer program.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This trial looks at a new imaging method to help doctors see brain tumors more clearly before surgery. It may help remove the tumor more safely and completely.
This study looks at the chemicals and genes in brain tumors called gliomas to find better ways to diagnose and treat them. People with a brain mass that needs surgery may be able to join.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
Hear when a new Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.